Selhorn Ryan J 4
4 · AYTU BIOPHARMA, INC · Filed Mar 3, 2025
Insider Transaction Report
Form 4
Selhorn Ryan J
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares
2025-02-05+105→ 16,000 total - Exercise/Conversion
Restricted Stock Units
2025-02-05−105→ 0 total→ Common Shares (105 underlying)
Footnotes (1)
- [F1]Restricted stock units (RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted February 5, 2022, vesting quarterly beginning February 5, 2023, and ending February 5, 2025.